Diss. (sammanfattning) Uppsala : Sveriges lantbruksuniv. / Härtill 3 uppsatser.

Diss. (sammanfattning) Stockholm : Karol. inst., 2004. / Härtill 5 uppsatser.

Diss. (sammanfattning) Stockholm : Karolinska institutet, 2005. / Härtill 5 uppsatser.

Diss. (sammanfattning) Uppsala : Uppsala universitet, 2007. / Härtill 4 uppsatser.

Thesis (Ph. D. in Chemistry)--Vanderbilt University, May 2006. / Title from title screen. Includes bibliographical references.

Thesis (MSc)--University of Stellenbosch, 2000. / ENGLISH ABSTRACT: Ribosome inactivating proteins (RIPs) are potent toxins produced by a wide range of evolutionarily diverse plants. These toxins cause cell death by physically dismantling ribosomal RNA and shutting down protein synthesis. They also have a strong antiviral activity. Some believe that the antiviral property of RIPs is a function of ribosomal inactivation, others believe that the two properties are unrelated. RIPs are non-specific in their antiviral activity. Transgenic RIPexpressing plants are resistant to a wide spectrum of viruses. Many different viruses threaten grapevine. It is not practical to design individual remedies for each of these viruses. In this study, we screen the grapevine genome for the presence of a RIP gene using degenerate PCR primers. If a RIP gene does exist in grapevine, it is not being expressed in a useful way. We also clone several well-documented RIP genes from various plants into pGEM-T Easy: dianthin from Dianthus caryophyllus; p-Iuffin from Luffa octandra and mirabilis antiviral protein (MAP) from Mirabilis jalapa. These isolated genes are then subcloned into a selection of expression vectors: dianthin into pKK223-3, a bacterial expression vector; p-Iuffin into pCambia3301, a plant expression vector; and MAP into pFLAG, a yeast expression vector. The constructs prepared in this project may be used for the synthesis of RIP molecules. The exogenous application of RIPs has been shown to protect plants from viruses. Transformation of grapevine with the RIP-containing plant expression vector may result in a variety of vine that is resistant to a wide range viruses. This thesis describes preliminary work in an attempt to impart broad-spectrum antiviral resistance to grapevine. / AFRIKAANSE OPSOMMING: Ribosomale-inaktiverende proteïne (RIPs) is kragtige toksienes wat deur 'n wye verskeidenheid evolusionêr diverse plante verskaf word. Hierdie toksienes veroorsaak die dood van die selle deur fisies die ribosomale RNA af te breek en proteïensintese stop te sit. Hulle toon ook 'n sterk antivirale aktiwiteit. Sommige voel dat die antivirale eienskap van RIPs 'n funksie van ribosomale inaktivering is, terwyl ander glo dat die twee eienskappe onafhanklik optree. RIPs is in hul antivirale aktiwiteit onspesifiek. Transgeniese RIP-weergewende plante toon weerstand teen 'n wye spektrum virusse. Wingerd word deur baie verskillende virusse aangeval. Dit is onprakties om spesifieke teenmiddels vir elk van die virusse te ontwerp. In hierdie studie word die wingerdgenoom vir die voorkoms van 'n RIP-geen ondersoek, deur die gebruik van degeneratiewe PKR primers. As daar wel 'n RIP-geen in wingerd voorkom, word dit nie in 'n nuttige manier uitgedruk nie. Ons het ook 'n groep goedgedokumentêre RIP-gene vanuit verskeie plante in pGEM- T Easy gekloneer: dianthin vanuit Dianthus caryophyllus; p-Iuffin vanuit Luffa octandra; en mirabilis antivirale proteïen (MAP) vanuit Mirabilis jalapa. Hierdie geïsoleerde gene is toe in verskeie uitdrukkingsvektore gesubkloneer: dianthin in pKK223-3, 'n bakterïele uitdrukkingsvektor; p-Iuffin in pCambia3301, 'n plant uitdrukkingsvektor; en MAP in pFLAG, 'n gis uitdrukkingsvektor. Die constructs wat in hierdie projek voorberei is, kan gebruik word vir die sintese van RIP molekules. Dit is gevind dat die eksogeniese toepassing van RIPs plante teen virus-infeksie beskerm. Die transformasie van wingerd met die RIP-bevattende plant ekspressievektor kan 'n wingerd wat teen 'n wye verskeidenheid virusse bestand is tot stand bring. Hierdie tesis beskryf die voorlopige werk in 'n poging om breë-spektrum antivirale weerstand in wingerd deelagtig te maak.

Orientadores: Clarice Weis Arns, Luciana Konecny Kohn / Dissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Biologia / Made available in DSpace on 2018-08-22T21:48:22Z (GMT). No. of bitstreams: 1 Bastos_JulianaCristinaSantiago_M.pdf: 1673040 bytes, checksum: 1234828d961406573d21b2476f1f1800 (MD5) Previous issue date: 2013 / Resumo: O vírus da Hepatite C (família Flaviviridae, gênero Hepacivirus) é causador de infecções crônicas em humanos, que podem evoluir para quadros de cirrose hepática e carcinoma hepatocelular. Até o momento, não há vacina disponível contra essa infecção e o tratamento disponível é caro, tem eficácia limitada e gera uma vasta gama de efeitos secundários, o que dificulta a continuidade do tratamento. Como esse vírus não replica eficientemente em cultura de células e em animais, o vírus da diarréia viral bovina é utilizado como modelo substituto para ensaios de avaliação de atividade antiviral e em ensaios de mecanismo de ação. A partir de invertebrados e micro-organismos marinhos, foram preparados extratos e frações, e algumas substâncias foram isoladas para a avaliação da sua possível atividade antiviral. Dos 422 testados, 5% foram considerados promissores e, destes, 20% mostraram-se ativos apresentando uma proteção de mais de 97% às células frente ao vírus. Os melhores resultados foram obtidos dos extratos produzidos a partir das amostras de esponjas Hyrtios sp. (BA07ES-56: PI=99%, IS=25), Aaptos sp. (BA07ES-59: PI=99%, IS=8,25) e de bactérias Bacillus sp. (555: PI=98%, IS>18; 584: PI=98%, IS=27) isoladas da esponja Petromica citrina. Os extratos e compostos promissores foram capazes de atuar em diversas etapas do ciclo replicativo viral (adsorção, penetração, etapas intracelulares do ciclo replicativo e também inativação da partícula viral), levando à sua interrupção quase completa nas condições analisadas. Desse modo, diversas substâncias presentes nesses organismos estudados são ativas e podem levar ao desenvolvimento de fármacos que garantam uma terapia alternativa para o tratamento da hepatite C / Abstract: The Hepatitis C virus (family Flaviviridae, genus Hepacivirus) causes chronic infections in humans, which can develop to liver cirrhosis and hepatocellular carcinoma. This represents a major public health problem worldwide. To this moment, there is no vaccine available against this infection and the treatment available is expensive, has limited efficacy and generates a wide range of side effects, making it difficult to continue the treatment. All this reflects the need to seek new agents with antiviral action against this virus. As this virus does not replicate efficiently in cell culture and in animals, bovine viral diarrhea virus is used as a surrogate model for screening assays of antiviral activity, and mechanism of action assays. From marine invertebrates and micro-organisms isolated from them, extracts and fractions were prepared, and substances were isolated for assessment of their possible antiviral activity. Of the 422 tested, 5% were considered promising, and of these, 20% were active presenting a protection percentage of more than 97%. The best results were obtained from the extracts produced from the samples of sponge Hyrtios sp. (BA07ES-56: IP=99%, SI=25), Aaptos sp. (BA07ES-59: IP=99%, SI=8,25) and bacteria Bacillus sp. (555: IP=98%, SI>18; 584: IP=98%, SI=27) isolated from the sponge Petromica citrina. The promising extracts and compounds acted in several stages of viral replicative cycle (adsorption, penetration, intracellular steps of the replicative cycle and also inactivation of the viral particle). Thus, various substances are active and may lead to the development of drugs which ensure an alternative therapy for the treatment of hepatitis C / Mestrado / Microbiologia / Mestra em Genética e Biologia Molecular

Orientador: Clarice Weis Arns / Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas / Made available in DSpace on 2018-08-18T22:42:12Z (GMT). No. of bitstreams: 1 Padilla_MarinaAiello_M.pdf: 819976 bytes, checksum: ee10d49c35496b65a75f47504870ce54 (MD5) Previous issue date: 2011 / Resumo: Os herpesvírus são responsáveis por enfermidades importantes em humanos e animais. Em animais, estão associados a doenças que causam grandes perdas econômicas. Em humanos, a gravidade da enfermidade é maior quando os pacientes são imunossuprimidos. Além disso, já existem cepas mutantes resistentes aos medicamentos disponíveis. Visto as dificuldades associadas a prevenção e tratamento das infecções por herpesvírus, a utilização de produtos de plantas como antivirais apresenta - se como alternativa. O Cerrado Brasileiro é um bioma que localiza -se praticamente todo no Brasil e apresenta mais de 10.000 espécies de plantas. Essas plantas podem potencialmente servi r de fonte de compostos farmacologicamente ativos. Assim, o presente trabalho teve como objetivos avaliar a atividade antiviral , atividade virucida e o índice de seletividade (SI) de extratos de plantas do Cerrado contra os herpesvírus suíno tipo 1 (SuHV-1), equinotipo 1 (EHV-1) e vírus do herpes simplex tipo 1 (HSV-1) . Inicialmente, os extratos liofilizados foram submetidos aos testes de citotoxicidade em células MDBK e Vero para determinar a concentração máxima não tóxica (CMNT). Dos extratos, quatro apresentaram as mesmas CMNT's em ambas as linhagens mas, em geral , os extratos foram mais citotóxicos para células Vero. A seguir, com base na CMNT, foram realizados os testes de atividade antiviral para os vírus HSV-1 e EHV-1 em células Vero, e SuHV-1 em MDBK. Os resultados demonstraram que 50% dos extratos apresentaram atividade contra pelo menos um dos herpesvírus estudados, com destaque para as espécies Banisteriopsis variabil is , Byrsonima intermedia e Xylopia aromática que foram ativas contra os t rês herpesvírus, e o extrato da Stryphnodendron adstringens , ativo contra o HSV-1 e SuHV-1. Os extratos que apresentaram atividade antiviral foram então testados quanto a atividade virucida e os resultados submetidos ao cálculo do SI. O extrato foi considerado ativo quando o índice de inibição viral ( IIV) foi maior ou igual a 1,5 ou apresentou PI% (porcentagem de inibição) maior ou igual a 97%. Quanto ao SI, foram considerados ativos os extratos que apresentaram valores iguais ou superiores a 4. A atividade virucida foi observada em 75% dos extratos contra pelo menos um dos herpesvírus testados. As espécies que apresentaram os resultados mais promissores foram: B. variabil is, X. aromática, S. adstringens e B. intermedia. Esta última foi então utilizada em testes adicionais com a variação da concentração, e demonstrou atividade antiviral e virucida em concentrações inferiores a CMNT contra os herpesvírus testados. Assim, o presente trabalho demonstra o potencial de plantas do Cerrado como fonte de compostos com atividade antiviral e virucida. Estudos adicionais são necessários para avaliar os mecanismos de ação e os compostos químicos responsáveis pela atividade observada / Abstract: Herpesviruses are responsible for important diseases in humans and animals. In animals, they are associated with economically important diseases worldwide. In humans, they represent serious threats to public health, and the severity of the illness increases in immunocompromised patients. In addition, there are mutant strains that are resistant to available drugs. Because of the difficulties associated with the prevent ion and treatment of herpesvirus infect ions, the use of plant products as antivirals can be an alternative. The Brazilian Cerrado is a biome located almost entirely in Brazil has over 10,000 species of plants. These plants can potentially be used as a source of pharmacologically active compounds. There for , this study aimed to evaluate the antiviral activity, virucidal activity and the selectivity index (SI) of extracts from Cerrado plants against suid herpesvirus type 1 (SuHV-1) equid type 1 (EHV-1) and herpes simplex virus type 1 (HSV-1). Initially, the lyophilized extracts were tested for cytotoxicity in MDBK and Vero cells to identify t he maximum nontoxic concentration (MNTC). Of the extracts, four showed the same MNTC for both cells, but the extracts were generally more toxic to Vero cells. Then, based on the MNTC, antiviral activity tests were performed against HSV-1 and EHV-1 in Vero cells and SuHV-1 in MDBK cells. The results demonstrated that 50% of the extracts showed activity against at least one of the herpesviruses studied. In particular, the extracts from Banisteriopsis variabil is, Byrsonima intermedia and Xylopia aromatica, were active against all of the herpesviruses, and the extract from Stryphnodendron adstringens was active against HSV-1 and SuHV-1. The extracts that showed antiviral activity were also tested for virucidal activity, and the SI was calculated. An extract was considered active when the viral inhibition index (VII) was greater than or equal to 1.5 or showed a PI% (percent inhibition) greater than or equal to 97%. As for the SI, extracts were considered active when the displayed values greater than or equal to four. Virucidal activity was observed in 75% of the extracts against at least one of the herpesviruses tested. The species that showed the most promising results were: B. variabil is , X. aromatica, S. adstringens and B. intermedia. Was used for additional testing with varying concentrations, and demonstrated antiviral and virucidal activities at concentrations lower than the MNTC against the herpesviruses tested. Therefore, this study demonstrates the potential of Cerrado as a source of compounds with antiviral and virucidal activities. Additional studies are necessary to evaluate the mechanisms of act ion and the chemical compounds responsible for the observed activity / Mestrado / Ciencias Basicas / Mestre em Clinica Medica

Orientadores: Clarice Weis Arns, Luciana Konecny Kohn / Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas / Made available in DSpace on 2018-08-21T23:34:00Z (GMT). No. of bitstreams: 1 Bianchi_BiancaReal_M.pdf: 1619930 bytes, checksum: 92df5dc0e4cba5e4314f506e39ff0be1 (MD5) Previous issue date: 2012 / Resumo: O vírus herpes simples do tipo 1 (HSV-1), agente etiológico do herpes labial em humanos, é facilmente transmitido e têm o grande problema de causar infecções latentes, sendo que uma vez infectado, o indivíduo passa a ser o portador do vírus por toda a vida. O medicamento mais apropriado contra este tipo de vírus deve ter ação inibitória em qualquer estágio de sua replicação, além de baixa toxicidade, para que as células do hospedeiro não sejam afetadas. Os organismos marinhos representam uma vasta biodiversidade que inclui cerca de 80% de todas as espécies do planeta, o que nos leva a uma grande quantidade de informações que ainda poderão ser descobertas, inclusive acerca de compostos com atividade antiherpética, já que atualmente temos poucos medicamentos disponíveis e nem sempre de total eficácia. Para o estudo com HSV-1 foi escolhida a cepa KOS, por ser resistente ao medicamento considerado mais eficaz para o herpes humano, o aciclovir. Foi utilizada a linhagem celular VERO para o estudo da atividade antiviral de extratos de organismos marinhos. Inicialmente foi realizada uma triagem com 129 extratos. Utilizou-se a concentração de 50?g/ml para todos os extratos, considerando ativos aqueles que apresentaram 97% de inibição do crescimento viral. Dentro dos grupos analisados foram identificados 6 extratos brutos de fungos e 7 extratos brutos de esponjas marinhas como possíveis antivirais. O cálculo do Índice de Seletividade foi realizado para as amostras de fungos Demateaceous (grupo) e Trichoderma sp., apresentando os valores 0,03 e 0,3, com atividade nas fases de adsorção e inativação viral, respectivamente e, para as amostras de esponjas, Monanchora arbuscula e Hemimycale sp., ambas apresentando o valor 0,1, com atividade também nas fases de adsorção e inativação viral, respectivamente / Abstract: Herpes simplex virus type 1 (HSV-1), the etiologic agent of herpes labialis in humans, is transmitted easily and have great problem to cause latent infections, and once infected, the individual becomes the carrier of the virus by life. The most suitable medicament against such virus should have inhibitory action at any stage of its replication as well as low toxicity to the host cells is not impaired. Marine organisms represent a wide biodiversity that includes about 80% of all species on the planet, which leads to a large amount of information that can still be found, including about compounds that may help a possible treatment of symptoms caused by this virus, since currently available medicines have few and not always fully effective. For the study of HSV-1, the KOS strain was chosen because it is resistant to the drug considered most effective for the human herpes, the acyclovir. Was used the cell lines VERO (African Green Monkey - ATCC CCL 81) for the study the antiviral activity of extracts of marine organisms. Initially was realized a screening with 129. We used the concentration of 50?g/ml for all the extracts, whereas those with active 97% inhibition of viral growth. Within the groups analyzed were identified 6 extracts of fungus and 7 crude extracts of marine sponges as possible antiviral. The calculation of the Selectivity Index was conducted for samples of fungi Demateaceous (group) and Trichoderma sp., presenting the values 0.03 and 0.3 with activity phases of adsorption and viral inactivation, respectively, and for samples of sponges, Monanchora arbuscula and Hemimycale sp. both presenting the value 0.1, with activity also in the phases of adsorption and viral inactivation, respectively / Mestrado / Clinica Medica / Mestra em Ciências

The Picornaviridae family contains a number of pathogens which are economically important including Poliovirus, Coxsakievirus, Hepatitis A Virus, and Foot-and-Mouth-Disease-Virus. Recently the emergence of novel picornaviruses associated with gastrointestinal, neurological and respiratory diseases in humans has been reported. Although effective vaccines for viruses such as FMDV, PV and HAV have been developed there are currently no antivirals available for the treatment of picornavirus infections. Picornaviruses proteins are classified as: the structural proteins VP1, VP2, VP3 and VP4 which form the subunits of the viral capsid and the replication proteins which function as proteases, RNA-polymerases, primers and membrane binding proteins. Although the host specificity and viral pathogenicity varies across members of the family, the icosahedral capsid is highly conserved. The capsid consists of 60 protomers, each containing a single copy of VP1, VP2 and VP3. A fourth capsid protein, VP4, resides on the internal side of the capsid. Capsid assembly is integral to life-cycle of picornaviruses; however the process is complex and not fully-understood. The overall aim of the study was to broaden the understanding of the evolution and function of the structural proteins across the Picornaviridae family. Firstly a comprehensive analysis of the phylogenetic relationships amongst the individual structural proteins was performed. The functions of the structural proteins were further investigated by an exhaustive motif analysis. A subsequent structural analysis of highly conserved motifs was performed with respect to representative enteroviruses, Foot-and-Mouth-Disease-Virus and Theiler’s Virus. This was supplemented by the in silico prediction of interacting residues within the crystal structures of these protomers. Findings in this study suggest that the capsid proteins may be evolving independently from the replication proteins through possible inter-typic recombination of functional protein regions. Moreover the study predicts that protomer assembly may be facilitated through a network of multiple subunit-subunit interactions. Multiple conserved motifs and principle residues predicted to facilitate capsid subunit-subunit interactions were identified. It was also concluded that motif conservation may support the theory of inter-typic recombination between closely related virus sub-types. As capsid assembly is critical to the viral life-cycle, the principle interacting motifs may serve as novel drug targets for the antiviral treatment of picornavirus infections. Thus the findings in the study may be fundamental to the development of treatments which are more economically feasible or clinically effective than current vaccinations.